The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients
Abstract
Objective (1) To determine chronic illness costs for large cohort of primary care patients, (2) to develop prospective model predicting total costs over one year, using demographic and clinical information including widely used comorbidity index.Study design and setting Data including diagnostic, medication, and resource utilization were obtained for 5,861 patients from practice-based computer system over a 1-year period beginning December 1, 1993, for retrospective analysis. Hospital cost data were obtained from hospital cost accounting system.Results Average annual per patient cost was $2,655. Older patients and those with Medicare or Medicaid had higher costs. Hospital costs were $1,558, accounting for 58.7% of total costs. In the predictive model, individuals with higher comorbidity incurred exponentially higher annual costs, from $4,317 with comorbidity score of two, to $5,986 with score of three, to $13,326 with scores greater than seven. To use an adapted comorbidity index to predict total yearly costs, four conditions should be added to the index: hypertension, depression, and use of warfarin with a weight of one, skin ulcers/cellulitis, a weight of two.Conclusion The adapted comorbidity index can be used to predict resource utilization. Predictive models may help to identify targets for reducing high costs, by prospectively identifying those at high risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Self-citationAdapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly
Wolff, J. L., Starfield, B. H., & Anderson, G. F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.20.2269 · Cited by 2,237
Reimbursing Health Plans and Health Providers: Efficiency in Production versus Selection
Newhouse, J. P. (1996) · RePEc: Research Papers in Economics · Cited by 565
Health care costs associated with depressive and anxiety disorders in primary care
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.352 · Cited by 555
Increased Medical Costs of a Population-Based Sample of Depressed Elderly Patients
Katon, W. J., Lin, E. H. B., Russo, J. E., & Unützer, J. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.897 · Cited by 500
The Growing Burden of Chronic Disease in America
Anderson, G. F., & Horvath, J. (2004) · Public Health Reports · doi:10.1016/j.phr.2004.04.005 · Cited by 494
Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups.
Pappas, G., Hadden, W. C., Kozak, L. J., & Fisher, G. F. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.5.811 · Cited by 399
Cited by
Sorted by citations
Items 201–300 of 891
Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease
Sparano, C., Zago, E., Morettini, A., Nozzoli, C., Yannas, D., Adornato, V., Caldini, E., Vaudo, M., Maggi, M., & Petrone, L. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01714-1 · Cited by 28
“Patients’ comorbidities were also computed according to the Charlson Comorbidity Index (CCI), to better stratify individual disease burden and prognosis [35, 36].”
MethodBaba, K., Guo, W., Chen, Y., Nosaka, T., & Kato, T. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04044-5 · Cited by 32
“The general health characteristics included body mass index (BMI), Charlson Comorbidity Index (CCI) [21, 22], smoking status, alcohol use, and exercise behavior.”
BackgroundInfluentialElli, C., Novella, A., Nobili, A., Ianes, A., & Pasina, L. (2022) · Medical Principles and Practice · doi:10.1159/000527063 · Cited by 28
Kuo, R. N.-C., & Lai, M. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-126 · Cited by 28
“Diagnosis based comorbidity scales and risk adjustment tools, such as the Charlson Comorbidity Index[1], Elixhauser index[2], the Johns Hopkins Adjusted Clinical Group (ACG) case-mix system[3], and the Diagnostic Cost Group Hierarchical Condition Category (DCG/HCC) model[4,5] have been verified for their effective use…”
Using Self‐Reported Health Measures to Predict High‐Need Cases among Medicaid‐Eligible Adults
Wherry, L., Burns, M. E., & Leininger, L. J. (2014) · Health Services Research · doi:10.1111/1475-6773.12222 · Cited by 30
“In addition, our selection of health conditions was informed by the CCI, but it may overlook other important chronic health conditions that influence health care utilization.”
Influential[Assessment of comorbidity in elderly].
Rosas‐Carrasco, Ó., González-Flores, E., Brito-Carrera, A. M., Valdez, O. V., Peschard-Sáenz, E., Gutiérrez‐Robledo, L. M., & García-Mayo, E. J. (2011) · PubMed · Cited by 28
Mausbach, B. T., Bos, T., & Irwin, S. A. (2018) · Health Psychology · doi:10.1037/hea0000670 · Cited by 27
“More recent evidence indicates the DCCI is also a useful predictor for physician visits, hospitalization, health service cost, and mortality (Charlson et al., 2008; Charlson, Pompei, Ales, & MacKenzie, 1987; Charlson, Szatrowski, Peterson, & Gold, 1994; Charlson, Wells, Ullman, King, & Shmukler,…”
Impact of opioid dose escalation on pain intensity: a retrospective cohort study
Hayes, C. J., Krebs, E. E., Hudson, T. J., Brown, J. D., Li, C., & Martin, B. C. (2020) · Pain · doi:10.1097/j.pain.0000000000001784 · Cited by 27
“Medical covariates included the enhanced Charlson comorbidity score and diagnoses for CNCP andmental health conditions (schizophrenia, major depressive disorder, post-traumatic stress disorder, anxiety disorders, bipolar disorder, multiple mental health conditions).(3) Medication classes used to treat pain or that inc…”
MethodImpact of electronic diabetes registry ‘Meaningful Use’ on quality of care and hospital utilization
Han, W., Sharman, R., Heider, A. R., Maloney, N., Yang, M., & Singh, R. K. P. G. (2015) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv040 · Cited by 28
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer
Ferrari, M., Mularoni, F., Smussi, D., Gaudioso, P., Bonomo, P., Friborg, J., Ghi, M. G., Grégoire, V., Harrington, K. J., Hunter, K. D., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00020-8 · Cited by 26
Bergman, S., Martelli, V., Monette, M., Sourial, N., Deban, M., Hamadani, F., Teasdale, D., Holcroft, C., Zakrzewski, H., & Fraser, S. A. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.07.387 · Cited by 25
Buja, A., Damiani, G., Gini, R., Visca, M., Federico, B., Donato, D., Francesconi, P., Marini, A., Donatini, A., Brugaletta, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091340 · Cited by 26
“The Charlson index was calculated to assess patients’ comorbidities: this index has proved a valid and reliable method for measuring comorbidities for the purpose of clinical research and, although it was first developed and validated for hospitalized patients, it has since been adapted and validated for primary care…”
MethodAngier, H. E., Marino, M., Springer, R. J., Schmidt, T. D., Huguet, N., & DeVoe, J. E. (2020) · Cancer · doi:10.1002/cncr.32900 · Cited by 26
“We did, however, adjust for the Charlson Comorbidity Index score, which considers diseases such as diabetes and heart disease.(37) There may be differential dropout of patients from expansion states in comparison with nonexpansion states leading to bias.”
MethodClare, L., Gamble, L. D., Martyr, A., Sabatini, S., Nelis, S. M., Quinn, C., Pentecost, C., Victor, C. R., Jones, R. W., Jones, I. R., et al. (2022) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbac022 · Cited by 26
“The Charlson Comorbidity Index age-adjusted score (Charlson et al., 2008) identified the number of chronic conditions.”
Yang, Q., Wang, J., Chen, Y., Lian, Q., Shi, Z., & Zhang, Y. (2022) · The Knee · doi:10.1016/j.knee.2022.02.006 · Cited by 27
Adams, A. M., Buse, D. C., Leroux, É., Lantéri‐Minet, M., Sakai, F., Matharu, M. S., Katsarava, Z., Reed, M. L., Fanning, K. M., Sommer, K., et al. (2023) · Cephalalgia · doi:10.1177/03331024231180611 · Cited by 28
“The Screening Module collected sociodemographic information and information on general health/comorbidities based on a modified Charlson Comorbidity Index (23).”
MethodPalacios‐Ceña, D., Hernández‐Barrera, V., Jiménez‐García, R., Valle-Martín, B., Fernández‐de‐las‐Peñas, C., & Carrasco‐Garrido, P. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.07.016 · Cited by 26
“The sheer growth in the older population ill likely result in an escalation in the absolute number of perons with morbidity [2] and disability [3], leading to substantial ncreases in both direct and indirect health care costs [4].”
BackgroundRöttger, J., Blümel, M., Engel, S., Grenz-Farenholtz, B., Fuchs, S., Linder, R., Verheyen, F., & Busse, R. (2015) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2015.97 · Cited by 26
Korsnes, J. S., Davis, K. L., Ariely, R., Bell, C. F., & Mitra, D. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.6.443 · Cited by 26
“The presence of cardiovascular risk factors, including age of at least 60 years at index, pre-index diabetes requiring treatment, pre-index renal disease, and index diagnosis of ST-elevation MI (STEMI) versus non-ST-elevation MI (NSTEMI; Appendix A, available in online article), as well as index statin use and the Cha…”
MethodThe Impact of Social and Clinical Complexity on Diabetes Control Measures
Cottrell, E., O'Malley, J. P., Dambrun, K., Park, B., Hendricks, M. A., Xu, H., Charlson, M. E., Bazemore, A., Shenkman, E. A., Sears, A., et al. (2020) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2020.04.190367 · Cited by 26
Self-citationHe, Z., Hou, H., Zhang, D., Mo, Y., La, Z., Su, G., Lin, J., Lu, L., Huang, J., Gu, Y., et al. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02070-7 · Cited by 25
“CCI was originally used to estimate the 1-year mortality rate of hospitalized patients [26].”
MethodHealth-Related Quality of Life Among Patients With HR+/HER2– Early Breast Cancer
Criscitiello, C., Spurden, D., Piercy, J., Rider, A., Williams, R., Mitra, D., Wild, R., Corsaro, M., Kurosky, S. K., & Law, E. H. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.04.020 · Cited by 25
Allen, K. S., Hood, D. R., Cummins, J., Kasturi, S., Mendonca, E. A., & Vest, J. R. (2023) · JAMIA Open · doi:10.1093/jamiaopen/ooad024 · Cited by 25
“These measures included age, gender, race, ethnicity, rural/urban status, Modified Townsend Index (social deprivation based on residential zip code),(43) and Charlson Comorbidity score.(44)”
MethodKurosky, S. K., Mitra, D., Zanotti, G., & Kaye, J. A. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.10.008 · Cited by 25
“The Charlson comorbidity index (CCI) (excluding cancer) was calculated to assess comorbidity burden.(12) Clinical characteristics were captured at the time of initial diagnosis and metastatic diagnosis.”
MethodKim, K., Kim, D., Lee, S., Cho, I. J., Shim, C. Y., Hong, G., & Ha, J. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0609 · Cited by 25
Smithman, M. A., Haggerty, J., Gaboury, I., & Breton, M. (2022) · BMC Primary Care · doi:10.1186/s12875-022-01850-4 · Cited by 25
“mortality, but has also been used to predict utilization and provides an assessment disease complexity and burden in administrative data [67, 68].”
MethodOddy, C., Zhang, J., Morley, J., & Ashrafian, H. (2024) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2024-101065 · Cited by 30
Alizai, P. H., Schulze-Hagen, M. F., Klink, C., Ulmer, T. F., Roeth, A. A., Neumann, U. P., Jansen, M., & Rosch, R. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1753-2 · Cited by 24
“Comorbidities in both groups were compared using the Charlson comorbidity index [29], a sum score where each comorbid condition is assigned to a score depending on its risk of death.”
Lepelley, M., Genty, C., Lecoanet, A., Allenet, B., Bedouch, P., Mallaret, M., Gillois, P., & Bosson, J. (2017) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzx168 · Cited by 24
Honda, S., Yanagi, Y., Koizumi, H., Chen, Y., Tanaka, S., Arimoto, M., & Imai, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-92567-4 · Cited by 23
Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study
Gamble, L. D., Matthews, F. E., Jones, I. R., Hillman, A. E., Woods, B. T., MacLeod, C. A., Martyr, A., Collins, R., Pentecost, C., Rusted, J. M., et al. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03086-4 · Cited by 25
“The number of health conditions was computed as previously described and in line with the scoring system of the Charlson Comorbidity Index [39, 40].”
MethodAssociation Between Migraine and Suicidal Behaviors: A Nationwide Study in the USA
Friedman, L. E., Zhong, Q., Gelaye, B., Williams, M. A., & Peterlin, B. L. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13235 · Cited by 24
Fried, D. A., Sadeghi‐Nejad, H., Gu, D., Zhou, S., He, W., Giordano, S. H., Pentakota, S. R., Demissie, K., Helmer, D. A., & Shen, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2109 · Cited by 24
Pant, N., Bushick, K., McAllister, A., Lee, W., Van de Walle, C., & Kioupakis, E. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506001212 · Cited by 24
Bermingham, M., Ryder, M., Travers, B., Edwards, N., Lalor, L., Kelly, D., Gallagher, J., O’Hanlon, R., McDonald, K., & Ledwidge, M. T. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.132 · Cited by 24
Patterns of treatment and correction of hyponatremia in intensive care unit patients
Dasta, J. F., Waikar, S. S., Xie, L., Boklage, S., Başer, O., Chiodo, J., & Badawi, O. (2015) · Journal of Critical Care · doi:10.1016/j.jcrc.2015.06.016 · Cited by 23
“Clinical characteristics included modified Charlson Comorbidity Index (CCI) score [23], Acute Physiology and Chronic Health Evaluation (APACHE IV) score [24], Acute Physiology Score [24,25], and Model for End-Stage Liver Disease (MELD) score [26]; outcome variables included hospital and ICU mortality, time to death, a…”
MethodZhang, R., Kyriss, T., Dippon, J., Hansen, M., Boedeker, E., & Friedel, G. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx436 · Cited by 23
“In this study, we adopted an updated version of the CCI that encompassed 23 medical conditions, which are summarized in Table 1 [11].”
MethodCosts of relapsed diffuse large B-cell lymphoma among Medicare patients
Huntington, S. F., Keshishian, A. V., McGuire, M., Xie, L., & Başer, O. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1459613 · Cited by 23
“Baseline characteristics included demographics (gender, age, race, and US geographic region), comorbidities defined as 1 claims identified via ICD-9-CM diagnosis codes (congestive heart failure, chronic obstructive pulmonary disease, cerebrovascular disease, depression, diabetes, kidney disease, liver disease, periphe…”
BackgroundTobe, K., Kubo, T., Okuyama, K., Kikuchi, M., Chen, Y., Schelfhout, J. E., Abe, M., & Tokita, S. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000832 · Cited by 23
Yakut, H., Dursun, H., Felekoğlu, E., Başkurt, A. A., Alpaydın, A. Ö., & Özalevli, S. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02867-x · Cited by 23
“Comorbidities are scored as 1, 2, 3, and 4, respectively, from mild to severe disease [13].”
BackgroundSandvik, H., Ruths, S., Hunskaar, S., Blinkenberg, J., & Hetlevik, Ø. (2022) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2022.2097617 · Cited by 23
The disease burden and quality of life of chronic cough patients in South Korea and Taiwan
Yu, C., Song, W., & Kang, S. H. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100681 · Cited by 23
Overton, M., Swain, N., Falling, C., Gwynne‐Jones, D., Fillingim, R. B., & Mani, R. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1082252 · Cited by 27
Liu, S., Qiang, L., Yang, Q., Fan, L., Wang, J., Yang, Y., Shi, Z., & Li, T. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06396-9 · Cited by 23
“The strategy described in previous studies was used in this study to assess the severity of these comorbidities [16, 17].”
MethodStaller, K. D., Barshop, K., Kuo, B., & Ananthakrishnan, A. N. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12628 · Cited by 23
Go, J. T., Vaughan‐Sarrazin, M., Auerbach, A. D., Schnipper, J. L., Wetterneck, T. B., Gonzalez, D. M., Meltzer, D. O., & Kaboli, P. J. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.612 · Cited by 23
“Comorbidity was measured using the Charlson comorbidity index.(23) Performance of early endoscopy, usually defined as endoscopy performed within 24 hours from presentation, was previously shown to decrease LOS and need for surgical intervention in patients with acute UGIH.”
MethodKeep it off: A phone-based intervention for long-term weight-loss maintenance
Sherwood, N. E., Crain, A. L., Martinson, B. C., Hayes, M. G., Anderson, J. D., Clausen, J. M., O’Connor, P. J., & Jeffery, R. W. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.03.011 · Cited by 23
“Exclusion criteria included 1) history of anorexia nervosa; 2) bariatric surgery; 3) modified Charlson [29] score≥3 (using prior-year diagnoses), non-skin cancer, or congestive heart failure; 4) participation in a phone-based weight-loss program; and 5) current participation in another weight-management researchstudy.”
Payment and economic evaluation of integrated care
Tsiachristas, A. (2015) · International Journal of Integrated Care · doi:10.5334/ijic.2009 · Cited by 23
Ornstein, K. A., Zhu, C. W., Bollens‐Lund, E., Aldridge, M. D., Andrews, H., Schupf, N., & Stern, Y. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000259 · Cited by 23
Risk of Psychiatric Disorders in Overactive Bladder Syndrome: A Nationwide Cohort Study in Taiwan
Tzeng, N., Chang, H., Chung, C., Kao, Y., Yeh, H., Yeh, C., Chiang, W.-S., Huang, S., Lu, R., & Chien, W. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000835 · Cited by 23
Continuity of care for newly diagnosed diabetic patients: A population-based study
Li, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221327 · Cited by 25
Identifying and characterizing cancer survivors in the US primary care safety net
Hoopes, M. J., Schmidt, T. D., Huguet, N., Winters‐Stone, K. M., Angier, H. E., Marino, M., Shannon, J., & DeVoe, J. E. (2019) · Cancer · doi:10.1002/cncr.32295 · Cited by 24
The Complexity of Complex Patients
Safford, M. M. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3472-6 · Cited by 23
Assessment of Morbidity Over Time in Predicting Health Outcomes
Zeng, C. X., Ellis, J. L., Steiner, J. F., Shoup, J. A., McQuillan, D. B., & Bayliss, E. A. (2014) · Medical Care · doi:10.1097/mlr.0000000000000033 · Cited by 23
Al-Amouri, F. M., & Badrasawi, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302990 · Cited by 22
El-Refai, S. M., Black, E. P., Adams, V. R., Talbert, J., & Brown, J. D. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.08.001 · Cited by 22
Clare, L., Martyr, A., Morris, R. G., & Tippett, L. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200407 · Cited by 20
“The number of co-morbid health conditions present alongside dementia was assessed with the Charlson Comorbidity Index [28, 29] and the age-adjusted score calculated.”
MethodHoopes, M. J., Voss, R., Angier, H. E., Marino, M., Schmidt, T. D., DeVoe, J. E., Soule, J., & Huguet, N. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa210 · Cited by 22
“These included household income as percent of federal poverty level, insurance type, race or ethnicity, preferred language, and Charlson Comorbidity Index (27); all time-varying characteristics were calculated using each patient’s latest visit.”
BackgroundInfluentialLau, S. C. L., Connor, L. T., & Baum, C. M. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaac065 · Cited by 24
Corrao, G., Soranna, D., Casula, M., Merlino, L. G., Porcellini, M. G., & Catapano, A. L. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.022 · Cited by 22
“Information additionally included: 1) the statin employed at starting therapy; 2) use of other drugs such as blood-pressure lowering agents, other cardiovascular, antidiabetic and antidepressant drugs during the 7-year time-window before the index prescription; 3) use of antibiotics and non-steroidal anti-inflammatory…”
MethodShaltout, H. A., Lee, S. W., Tegeler, C. L., Hirsch, J. R., Simpson, S. L., Gerdes, L., & Tegeler, C. H. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00116 · Cited by 22
“An additional model was tested that included age, gender, current beta-blocker usage, and the revised Charlson comorbidity score (25) as covariates.”
MethodCichos, K. H., Lehtonen, E., McGwin, G., Ponce, B. A., & Ghanem, E. S. (2018) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-18-00312 · Cited by 22
Lacy, B. E., Ayyagari, R., Guérin, A., Lopez, A., Shi, S., & Luo, M. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818818326 · Cited by 22
Association between quality of care and complications after abdominal surgery
Bergman, S., Deban, M., Martelli, V., Monette, M., Sourial, N., Hamadani, F., Teasdale, D., Holcroft, C., Zakrzewski, H., & Fraser, S. A. (2014) · Surgery · doi:10.1016/j.surg.2013.12.031 · Cited by 22
Oregon Medicaid Expenditures After the 2014 Affordable Care Act Medicaid Expansion
Springer, R., Marino, M., O'Malley, J., Lindner, S., Huguet, N., & DeVoe, J. (2018) · Medical Care · doi:10.1097/mlr.0000000000000907 · Cited by 18
Ajinkya, S., Fox, J., & Lekoubou, A. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.106973 · Cited by 21
Austin, D. C., Torchia, M. T., Tosteson, A. N. A., Gitajn, I. L., Tapp, S. J., & Bell, J. (2020) · PubMed Central · Cited by 21
Hemelrijck, M. V., Ventimiglia, E., Robinson, D., Gedeborg, R., Holmberg, L., Stattin, P. E., & Garmo, H. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01766-0 · Cited by 21
“Charlson Comorbidity Index (CC) [10] was calculated based on data on discharge diagnoses in the National Patient Registry [11].”
MethodCompletion of Recommended Tests and Referrals in Telehealth vs In-Person Visits
Zhong, A., Amat, M. J., Anderson, T. S., Shafiq, U., Sternberg, S. B., Salant, T., Fernández, L., Schiff, G. D., Aronson, M. D., Benneyan, J. C., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.43417 · Cited by 21
McAdam‐Marx, C., Nguyen, H. P., Schauerhamer, M. B., Singhal, M., Unni, S. K., Ye, X., & Cobden, D. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.11.003 · Cited by 21
“Additional baseline characteristics were captured in the 13 months before the index date to describe the study cohort and to control for confounding, including age, sex, race, baseline HbA1c, body mass index, weight, blood pressure, select comorbidities (by diagnosis codes), and the Charlson Comorbidity Index (CCI).(1…”
MethodCorrao, G., Compagnoni, M. M., Rea, F., Merlino, L. G., Catapano, A. L., & Mancia, G. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.008 · Cited by 22
Torres, M. R., Valenzuela, R. E. R., Esparza‐Romero, J., López-Teros, M. T., & Alemán-Mateo, H. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.02.013 · Cited by 21
Parikh, R. C., Lorenzo, M., Hess, L. M., Candrilli, S. D., Nicol, S. J., & Kaye, J. A. (2018) · Clinical Sarcoma Research · doi:10.1186/s13569-018-0094-x · Cited by 21
van Isselt, E. F. V. D., van Eijk, M., van Geloven, N., Groenewegen-Sipkema, K. H., van den Berg, J. W., Nieuwenhuys, C. M. A., Chavannes, N. H., & Achterberg, W. P. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.02.025 · Cited by 21
Shin, J., Kunisawa, S., & Imanaka, Y. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.06.011 · Cited by 21
Sleep Quality in Patients with Heart Failure in the Spanish Population: A Cross-Sectional Study
Jorge-Samitier, P., Durante, Á., Gea-Caballero, V., Antón‐Solanas, I., Fernández‐Rodrigo, M. T., & Juárez‐Vela, R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17217772 · Cited by 21
“The Charlson comorbidity index (CCI) predicts the ten-year mortality for a patient who may have a range of comorbid conditions and was used to identify the presence of other pathologies in our sample [24].”
MethodToxicity-Related Factors Associated With Use of Services Among Community Oncology Patients
Harrison, J. M., Stella, P. J., Lavasseur, B. I., Adams, P. T., Swafford, L., Lewis, J., Mendelsohn‐Victor, K., & Friese, C. R. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.010959 · Cited by 21
Tourneau, C. L., Takácsi‐Nagy, Z., Nuyts, S., Thureau, S., Liu, F., Hoffmann, C., Hackman, T., Lesnik, M., Debard, A., Finzi, L., et al. (2025) · Future Oncology · doi:10.1080/14796694.2025.2496131 · Cited by 20
“…negative prognostic factors, including the majority of patients having a high burden of comorbidities as 67% of patients had an Age-adjusted modified Charlson Comorbidity Index (ACCI) ≥4 [38], which has been shown to correlate with a worse survival for patients with head and neck cancer [32,38,39].”
Li, Q., Chitnis, A. S., Hammer, M., & Langer, J. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0084-9 · Cited by 20
“Baseline clinical characteristics included type of provider for the index therapy (primary care physician, endocrinologists, and other types) and several measures identified over the 6-month washout period: Charlson Comorbidity Index adapted to predict healthcare costs [15], the occurrence of common diabetes-related c…”
BackgroundEffect of comorbidities and medications on frequency of primary care visits among older patients.
Hu, T., Dattani, N. D., Cox, K. A., Au, B., Xu, L., Melady, D., Jaakkimainen, L., Jain, R., & Charles, J. (2017) · PubMed Central · Cited by 20
Bélanger, E., Silver, B. C., Meyers, D. J., Rahman, M., Kumar, A., Kosar, C. M., & Mor, V. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4781-3 · Cited by 20
Brufsky, A., Mitra, D., Davis, K. L., Nagar, S. P., McRoy, L., Cotter, M. J., & Stearns, V. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.04.005 · Cited by 20
Jean, S., Mac‐Thiong, J., Jean, M.-C., Dionne, A., Bégin, J., & Richard‐Denis, A. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001812 · Cited by 20
“The ability to predict independent functional walking capacity in the chronic phase as early as possible is a major asset for healthcare professionals and patients alike, as it allows for better planning of rehabilitation resources and helps set realistic expectationswith patients (notably with regard to home accessib…”
BackgroundMatsunuma, R., Matsumoto, K., Yamaguchi, T., Sakashita, A., & Kizawa, Y. (2022) · Palliative Medicine Reports · doi:10.1089/pmr.2021.0063 · Cited by 20
“Medication, n (%) ACE 14 (14) ARB 46 (46) b-Blocker 88 (88) MRA 34 (34) Statin 31 (31) Diuretic agents 51 (51)”
Kane, J. M., Chen, A., Lim, S., Mychaskiw, M. A., Tian, M., Wang, Y., Suett, M., & Rubio, J. M. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000452 · Cited by 20
Dai, D., Coetzer, H., Zion, S. R., & Malecki, M. J. (2023) · Journal of health economics and outcomes research · doi:10.36469/jheor.2023.70238 · Cited by 20
Sabatini, S., Martyr, A., Hunt, A., Gamble, L. D., Matthews, F. E., Thom, J. M., Jones, R. W., Allan, L. M., Knapp, M. R. J., Quinn, C., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04707-w · Cited by 22
“Health conditions were assessed with the Charlson Comorbidity Index (CCI) [53, 54].”
BackgroundMethodInfluentialBoland, M. R. S., van Boven, J. F. M., Kocks, J. W. H., van der Molen, T., Goossens, L. M. A., Chavannes, N. H., & Mölken, M. R. (2015) · Value in Health · doi:10.1016/j.jval.2014.11.006 · Cited by 20
“[21] Charlson ME, Charlson RE, Peterson JC, et al.”
BackgroundResultThe pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria
Salako, O., Okediji, P. T., Habeebu, M. Y., Fatiregun, O. A. A., Awofeso, O. M., Okunade, K. S., Odeniyi, I. A., Salawu, K., & Oboh, E. O. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.843 · Cited by 20
“The CCI has been used extensively to assess comorbidity burden across populations [33], assess risk of mortality in groups of patients [10], predict costs of treating chronic illnesses [17, 34], and predict a variety of malignancies and other clinical outcomes.”
MethodTsai, Y., Hsu, C., Chang, G., Tsai, M., Lee, Y., Huang, E. I., Lai, C., & Fang, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.609314 · Cited by 20
Prevalence of Chronic Pain in a Large Integrated Healthcare Delivery System in the U.S.A
Lamerato, L. E., Dryer, R. D., Wolff, G. G., Hegeman‐Dingle, R., Mardekian, J., Park, P. W., & Zlateva, G. (2015) · Pain Practice · doi:10.1111/papr.12334 · Cited by 20
“pain diagnosis, the database was queried to obtain the number of pain conditions, the number of neuropathic pain conditions, and the presence/absence of medical conditions as defined by the Charlson comorbidity index and score.(9) The period of 6 months pre-index was used for identification of comorbid conditions, inc…”
MethodBoland, M. R. S., van Boven, J. F. M., Kruis, A. L., Chavannes, N. H., van der Molen, T., Goossens, L. M. A., & Mölken, M. R. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.11.008 · Cited by 21
“the FEV1%pred at baseline, the total exacerbation rate (moderate or severe) in the 12months prior to the adherencemeasurement, theMRC dyspnoea scale [23] at the start of the adherence measurement and the Charlson comorbidity index at baseline [24].”
BackgroundMethodCost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States
Li, Q., Chen, S.-Y., Burstin, S., Levin, M., & Suaya, J. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw067 · Cited by 19
“The Charlson Comorbidity Index (CCI) adapted to predict healthcare costs were estimated based on medical claims during the 6-month preindex period [15].”
MethodShiber, S., & Molad, Y. (2014) · Medicine · doi:10.1097/md.0000000000000152 · Cited by 20
Goyal, R., Nagar, S. P., Kabadi, S., Kaye, J. A., Seal, B. S., & Mato, A. R. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1509320 · Cited by 20
“Demographic and other baseline characteristics, including Charlson Comorbidity Index (CCI) score, were assessed on the index date or during the 12month baseline period [14].”
MethodGläser, E., Kilimann, I., Platen, M., Hoffmann, W. U., Brosseron, F., Büerger, K., Coenjaerts, M., Düzel, E., Ewers, M., Fließbach, K., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01785-9 · Cited by 19
Hatch, B., Hoopes, M. J., Darney, B. G., Marino, M., Templeton, A. R., Schmidt, T. D., & Cottrell, E. (2020) · Women s Health Issues · doi:10.1016/j.whi.2020.08.011 · Cited by 19
“Women from expansion state CHCs had slightly higher levels of medical complexity (Charlson Comorbidity Index ≥3: 21.5% vs. 16.9% of nonexpansion patients), as well as higher ambulatory visit rates (mean annual visits, 2.9 expansion vs. 2.1 nonexpansion).”
MethodInfluentialVedin, T., Forberg, J. L., Anefjäll, E., Lehtinen, R., Faisal, M., & Edelhamre, M. (2022) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-022-02016-8 · Cited by 19
Poirrier, J., Meyers, J., Nagar, S. P., Patterson, B. J., Glasser, L., & Jabbour, S. A. (2022) · Diabetes Care · doi:10.2337/dc21-2053 · Cited by 22
“Covariates included in propensity score matching included age, sex, health plan type, modified Charlson-Quan comorbidity index (CCI) score (18,19), and baseline health care costs (as measured in the 12 months prior to the index date).”
MethodDai, D., Sharma, A. K., Phillips, A. L., & Lobo, C. P. (2022) · Journal of health economics and outcomes research · doi:10.36469/jheor.2022.38669 · Cited by 19
Metadata
- Authors
- Charlson, M. E., Charlson, R. E., Peterson, J. C., Marinopoulos, S. S., Briggs, W. M., & Hollenberg, J. P.
- Affiliations
- Weill Cornell Medicine (US)
- Yale New Haven Hospital (US)
- Johns Hopkins University (US)
- Central Michigan University (US)
- Corresponding author
- Charlson, Mary E.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 61
- Issue
- 12
- Pages
- 1234-1240
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2110548428
- Cited by
- 894
- References
- 38
- Citations by year
- 2026: 35 · 2025: 52 · 2024: 79 · 2023: 74 · 2022: 80 · 2021: 77 · 2020: 81 · 2019: 66 · 2018: 83 · 2017: 56 · 2016: 42 · 2015: 51 · 2014: 37 · 2013: 21 · 2012: 22
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Keywords
- Charlson Comorbidity Index, chronic disease costs, health care costs, primary care patients, cost prediction model, hospital costs, resource utilization (health care), hypertension, depression, warfarin, skin ulcers, cellulitis, Medicare and Medicaid, elderly patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Chronic Disease, Epidemiologic Methods, Female, Health Resources, Health Services Research, Hospitalization, Humans, Male, Middle Aged, New York City, Primary Health Care, Prognosis, Drug Costs, Health Care Costs, Hospital Costs, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review